UK markets open in 5 hours 48 minutes
NIKKEI 225
26,740.19 -309.28 (-1.14%) HANG SENG
22,418.97 +189.47 (+0.85%) CRUDE OIL
111.57 -0.19 (-0.17%) GOLD FUTURES
1,819.70 -1.50 (-0.08%) DOW
30,946.99 -491.31 (-1.56%) BTC-GBP
16,598.50 -507.45 (-2.97%)
Infinity Pharmaceuticals, Inc. (INFI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.6915 |
| Open | 0.6800 |
| Bid | 0.6400 x 1200 |
| Ask | 0.6770 x 3200 |
| Day's range | 0.6300 - 0.7313 |
| 52-week range | 0.4600 - 3.8900 |
| Volume | |
| Avg. volume | 913,359 |
| Market cap | 57.282M |
| Beta (5Y monthly) | 2.18 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Is Infinity Pharmaceuticals (NASDAQ:INFI) In A Good Position To Invest In Growth?
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
- Zacks
Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates
Infinity (INFI) delivered earnings and revenue surprises of 0% and 65.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Even after rising 21% this past week, Infinity Pharmaceuticals (NASDAQ:INFI) shareholders are still down 64% over the past year
Infinity Pharmaceuticals, Inc. ( NASDAQ:INFI ) shareholders should be happy to see the share price up 24% in the last...
© 2022 Yahoo. All rights reserved.
